Core Insights - Telescope Innovations Corp. reported Q1 financial results for the fiscal quarter ended November 30, 2025, with revenues of CAD 2.7 million, a significant increase from CAD 1.2 million in Q1 FY2025, driven by product sales and new service offerings [1][5] - The company experienced an adjusted EBITA loss of CAD 829,000, compared to a loss of CAD 100,000 in the previous fiscal year [5] - The financial results align with management's budget expectations and FY 2026 targets, indicating a strategic reinvestment in operational growth [1][4] Financial Highlights - Revenues for Q1 FY2026 reached CAD 2.7 million, up from CAD 1.2 million in Q1 FY2025 [5] - Total expenses increased to CAD 3.92 million from CAD 1.55 million in Q1 FY2025 [5] - Contract Research Services generated CAD 820,000 in revenue, compared to CAD 380,000 in Q1 FY2025 [5] Operational Highlights - The company delivered its first Self Driving Laboratory (SDL) to the Korean Pharmaceutical BioPharmaceutical Manufacturers' Association (KPBMA) [5] - The proprietary ReCRFT™ process achieved over 99.9% pure Li2CO3 from battery recycling brines, with materials shipped to Cellmine Ltd. and the University of St. Andrews for testing [5] - The company received conditional approval for CAD 3.6 million in government funding for lithium recycling and solid-state battery materials technologies [5]

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it has authorized the grant of incentive stock options (the "Options"), restricted share units (the "RSUs") as well as the issuance of common shares to settle outstanding fees owed to its CEO.Stock Option GrantThe Company ...

Core Insights - Telescope Innovations Corp. reported revenues of $5.8 million for the fiscal year ended August 31, 2025, an increase from $4.4 million in FY 2024, while experiencing an Adjusted EBITDA loss of $402,000 compared to a loss of $152,000 in the previous year [1][8]. Operational Highlights - The company achieved significant milestones, including continued progress on the Self-Driving Lab (SDL) program with Pfizer and record sales of DirectInject-LC™ [4][8]. - Telescope Innovations successfully produced battery-grade lithium sulfide using a proprietary low-temperature method, with initial samples shipped to battery industry groups in North America and Asia [8]. Financial Highlights - Total expenses for FY 2025 were $7.3 million, up from $5.8 million in FY 2024 [8]. - The company is strategically reinvesting revenues to enhance research and development (R&D) and commercialization capacity, indicating a focus on long-term growth [1][4].

Telescope Innovations Installs Korea's First Self-Driving Lab for Pharma R&D and EducationRapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating commercial momentumDecember 09, 2025 8:00 AM EST | Source: Telescope Innovations Corp.HIGHLIGHTS Telescope Innovations' installation of Korea's first Self-Driving Lab for pharmaceutical research completed just three weeks after contract signing Project facilitated by collab ...

Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers AssociationKorea's leading biopharma association selects Telescope's Self-Driving Lab to anchor the country's first AI-driven training hubNovember 17, 2025 8:00 AM EST | Source: Telescope Innovations Corp.HIGHLIGHTSThis installation for Korea's largest biopharma association represents the first Self-Driving Lab ("SDL") for drug development to be deployed in KoreaPartnership supports Korea's tran ...

Core Insights - Telescope Innovations Corp. has been conditionally approved for up to CAD $3.36 million in government funding to advance its lithium processing technologies, announced by Canada's Minister of Energy and Natural Resources during the G7 Energy and Environment Ministers' meeting [1][2]. Funding and Support - The company is receiving up to CAD $319,200 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) for demonstrating its lithium carbonate crystallization technology, ReCRFT™, aimed at battery recycling [2]. - An additional CAD $3.04 million has been conditionally approved through Natural Resources Canada's Critical Minerals Research, Development and Demonstration (CMRDD) program to scale up and pilot the DualPure™ process, which focuses on producing high-purity lithium sulphide [2]. Technological Advancements - Telescope Innovations is advancing its lithium carbonate recovery and lithium sulphide synthesis technologies, contributing to the on-shoring of advanced battery materials manufacturing [5]. - The ReCRFT™ technology has progressed from research to demonstration within one year, aligning with the increasing global demand for a circular lithium supply [6]. - The DualPure™ process is also moving towards commercialization, coinciding with the rising demand for high-purity lithium sulphide from global battery manufacturers [6]. Strategic Collaboration - The company is collaborating with international partners under the G7 Critical Minerals Action Plan to enhance critical mineral supply chains, focusing on sustainability and competitiveness [3][4]. Automation and R&D Model - Telescope's intelligent automation laboratory infrastructure supports both lithium refinement programs, enabling rapid iteration and cost-effective development of new chemical processes [7]. - The automation-first R&D model allows for faster transition from proof-of-concept to demonstration and scale-up, generating data-rich insights essential for deployment [7]. Company Overview - Telescope Innovations is a chemical technology company focused on developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries, utilizing robotic platforms and AI to improve efficiency and data quality [8].

Vancouver, British Columbia--(Newsfile Corp. - October 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce that it has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a "Share") of the Company (the "Debt Settlement").Pursuant to the Debt Settlement, ...

Telescope Innovations Selected to Join ALTA: the First US-Based Lithium Technology AcceleratorTelescope is among the first tech companies invited to the Arkansas Lithium Technology Accelerator (ALTA), engaging with industry leaders on the commercialization pathways for its lithium processing technologiesJuly 24, 2025 8:00 AM EDT | Source: Telescope Innovations Corp.Vancouver, British Columbia--(Newsfile Corp. - July 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:4JU) ( ...